|Day Low/High||20.87 / 21.18|
|52 Wk Low/High||20.55 / 31.29|
U.S. stocks attempted to reverse the global tide Wednesday, with futures improving after better-than-expected earnings from Boeing and Twitter and a spate of multi-billion merger deals at home and abroad.
U.S. stock futures point to further losses for Wall Street and global stocks slump on Wednesday; Facebook, Boeing and AMD report earnings; Takeda sweetens offer for Shire.
As Wall Street prepares for another rough day, these are the business stories you must know.
Global stocks are on the defensive Wednesday, pulling U.S. futures and European shares lower, as investor re-set expectations for corporate profits in the face of rising investment and input costs.
I think M&A activity will pick up markedly going forward across the industry.
Stocks rise Monday as concerns over prolonged military action in Syria fade and the focus for investors shifts to a heavy upcoming slate of U.S. corporate earnings.
Data and industry conferences will likely be catalysts for shares in the space.
U.S. equity futures gave back earlier gains Monday even as investor concern over prolonged military action in Syria faded following weekend missile strikes in reaction to an alleged chemicals weapons attack last week in the city of Douma.
Shire will sell its oncology business to France's Servier for around $2.4 billion as it contemplates a possible $50 billion takeover from Japan's Takeda Pharmaceutical Co.
Oil remained near a three-year high despite falling back slightly on Thursday.
China on Friday said it would counter Trump's proposed new tariffs 'to the end, and at any cost'
Wall Street is also expected to start the day in positive territory on Thursday after tumultuous trading on Wednesday.
Strength in the morning yields to weakness in the afternoon session as stocks are sold off Wednesday.
Shire Pharmaceuticals shares hit a year-to-date high Wednesday after Japan's biggest drugmaker, Takeda, confirmed it may make a takeover approach for the U.K.-listed group.
Deal combines Mindstrong's digital phenotyping platform with Takeda's development capabilities
Annual Award Spotlights Takeda's Local Workforce Talent and Commitment to Enhancing Employee Development
Takeda's Commitment to Investing in Deerfield Operations Yields Positive Employee Survey Results
Animal health and oncology deal activity is heating up in 2017.
Sign up to get started or log in to see your watchlist.
Enter a symbol above to add it to your watchlist.